Generation Bio News

News

Ticker

GBIO

ISIN

US37148K2096

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Generation Bio Eulerpool News

Generation Bio Stock News

Generation Bio is being monitored by journalists and investors worldwide. We gather the latest Generation Bio news here.

December 15 ·
Benzinga
Trading Halt: Halt status updated at 5:25:00 PM ET: Quotation Resumption: News and Resumption Times
December 15 ·
Benzinga
XOMA Royalty To Acquire Generation Bio Co. For A Cash Price Of $4.2913 Per Share At The Closing Of The Merger
December 2 ·
Yahoo
Here's Why We're A Bit Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation
November 5 ·
Yahoo
Generation Bio Announces Third Quarter 2025 Financial Results
October 22 ·
Yahoo
Generation Bio Announces CEO Transition
August 13 ·
Yahoo
Generation Bio Shares Surge Following Restructuring Plans, Q2 Results
August 13 ·
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 12 ·
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 12 ·
Benzinga
Generation Bio Announces Data Demonstrating Its Cell-Targeted Lipid Nanoparticle Selectively Delivered siRNA To T Cells In Non-Human Primates
July 18 ·
Yahoo
Generation Bio Announces 1-for-10 Reverse Stock Split
June 25 ·
Yahoo
We're Keeping An Eye On Generation Bio's (NASDAQ:GBIO) Cash Burn Rate
May 28 ·
Yahoo
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
May 7 ·
Yahoo
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
April 2 ·
Yahoo
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
March 13 ·
Yahoo
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates
January 23 ·
Yahoo
3 US Penny Stocks With Market Cap Under $70M
January 16 ·
Yahoo
Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely?
January 6 ·
Yahoo
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
December 2 ·
Yahoo
US Penny Stocks Spotlight: LiveOne And 2 Other Promising Picks
November 10 ·
Yahoo
Earnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Generation Bio Stock Press Releases

Generation Bio regularly publishes news on the company's website that are relevant for investors.

January 3 •
Generation Bio
Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
November 3 •
Generation Bio
Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results
September 22 •
Generation Bio
Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit
September 20 •
Generation Bio
Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer
August 4 •
Generation Bio
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results
August 2 •
Generation Bio
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference
July 18 •
Generation Bio
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors
June 21 •
Generation Bio
Generation Bio Announces Update to Its GMP Manufacturing Strategy
June 2 •
Generation Bio
Generation Bio to Present at the 2022 Jefferies Healthcare Conference
May 5 •
Generation Bio
Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results
April 5 •
Generation Bio
Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference
March 2 •
Generation Bio
Generation Bio to Participate in 42nd Annual Cowen Health Care Conference
February 24 •
Generation Bio
Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results
February 10 •
Generation Bio
Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer
January 5 •
Generation Bio
Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference
December 14 •
Generation Bio
Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program
November 10 •
Generation Bio
Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results
October 22 •
Generation Bio
Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery of ceDNA and mRNA at the European Society of Gene and Cell Therapy 2021 Annual Virtual Congress
October 21 •
Generation Bio
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit
October 15 •
Generation Bio
Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress
August 11 •
Generation Bio
Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results
August 3 •
Generation Bio
Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021
July 14 •
Generation Bio
Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update
July 8 •
Generation Bio
Generation Bio to Present at William Blair Biotech Focus Conference
June 9 •
Generation Bio
Generation Bio to Present at the JMP Securities Life Sciences Conference
May 27 •
Generation Bio
Generation Bio to Present at the Jefferies Virtual Healthcare Conference
May 12 •
Generation Bio
Generation Bio Presents Preclinical Data Demonstrating Broad Potential of Gene Therapy Platform at ASGCT and Reports First Quarter Financial Results
April 27 •
Generation Bio
Generation Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting
April 8 •
Generation Bio
Generation Bio to Present at 20th Annual Needham Virtual Healthcare Conference
March 18 •
Generation Bio
Generation Bio Reports Fourth Quarter and Full Year 2020 Financial Results

Generation Bio News 2026

This page contains all current news, analysis and press releases for Generation Bio stock (GBIO, ISIN: US37148K2096). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Generation Bio.